The EPS projection of Imax Corporation (NYSE:IMAX) for quarter ended 2016-09-30 is $0.15. Last week, the projection for EPS was $0.15 against target of $0.15, a month earlier. While 2-months ago, this projection was $0.15 versus forecast of $0.15a quarter months earlier, posting a deviation of 0%.
Imax Corporation (NYSE:IMAX) posted that 18 days earlier, the share price was revised 2 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 1 times and positive EPS revisions were 1 times. In last one-month and two month the positive revisions were 1 and 1. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for Imax Corporation (NYSE:IMAX) in the preceding 30 and 120 were 2 and 3. While in 60 and 90 days were 2, and 3, in that order.
Imax Corporation (NYSE:IMAX) EPS target was $0.15 for the quarter closed 1. It was based on 4 calls. As on 2016-04-21 the EPS was $0.14. The change was $0.05, posting a deviation of 55.56%. The price projections gave a standard deviation of 0.02.
Quarterly Sales Estimates
Imax Corporation (NYSE:IMAX) sales prediction for the fiscal 2017 stands at $132.738 and the median estimate is at $134.612. Almost 4 analysts gave sales target.
Among this, the highest sales estimate is $139.73 while the lowest target is $122 showing standard deviation of 8.545%.
As many as 4 analysts have positive sales targets revision while 4 reduced sales estimates, posting a deviation of -0.966%.
Last month, 4 experts have positive sales number revision. Also, 4 research groups lowered the sales projections, posting a deviation of -0.966%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast, posting a deviation of 5.456%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...